Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wehling

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Clinical Chemistry and Laboratory Medicine|February 27, 2015
Determination of dabigatran in plasma, serum, and urine samples: comparison of six methodsShanshan Du, Christel Weiss, Giese Christina, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Modulation of angiotensin II-mediated signalling by heparan sulphate glycosaminoglycansHannes Köppel, Benito A Yard, Michael Christ, et al.
Journal of the American College of Cardiology|January 15, 2002
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expressionJohann Bauersachs, Marina Heck, Daniela Fraccarollo, et al.
European Journal of Clinical Pharmacology|December 3, 2017
Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatmentsFarhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, et al.
Drugs & Aging|December 23, 2018
Higher Fit-fOR-The-Aged (FORTA) Scores Comprising Medication Errors are Associated with Impaired Cognitive and Physical Function Tests in the VALFORTA TrialFarhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, et al.
International Journal of Cardiology|July 10, 2002
Acute effects of aldosterone on intracardiac monophasic action potentialsHanns-Christian Tillmann, Burghard Schumacher, Oleksiy Yasenyev, et al.
Age and Ageing|January 21, 2016
VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classificationMartin Wehling, Heinrich Burkhardt, Alexandra Kuhn-Thiel, et al.
Biochemical and Biophysical Research Communications|April 28, 2004
Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosteroneKarin Rossol-Haseroth, Qian Zhou, Sabine Braun, et al.
Thrombosis and Haemostasis|September 28, 2012
Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgeryJob Harenberg, Svetlana Marx, Ola E Dahl, et al.
Kidney International|September 13, 2003
Early aldosterone up-regulated genes: new pathways for renal disease?Markus Kellner, Angela Peiter, Mathias Hafner, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Clinical Chemistry and Laboratory Medicine|February 27, 2015
Determination of dabigatran in plasma, serum, and urine samples: comparison of six methodsShanshan Du, Christel Weiss, Giese Christina, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Modulation of angiotensin II-mediated signalling by heparan sulphate glycosaminoglycansHannes Köppel, Benito A Yard, Michael Christ, et al.
Journal of the American College of Cardiology|January 15, 2002
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expressionJohann Bauersachs, Marina Heck, Daniela Fraccarollo, et al.
European Journal of Clinical Pharmacology|December 3, 2017
Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatmentsFarhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, et al.
Drugs & Aging|December 23, 2018
Higher Fit-fOR-The-Aged (FORTA) Scores Comprising Medication Errors are Associated with Impaired Cognitive and Physical Function Tests in the VALFORTA TrialFarhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, et al.
International Journal of Cardiology|July 10, 2002
Acute effects of aldosterone on intracardiac monophasic action potentialsHanns-Christian Tillmann, Burghard Schumacher, Oleksiy Yasenyev, et al.
Age and Ageing|January 21, 2016
VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classificationMartin Wehling, Heinrich Burkhardt, Alexandra Kuhn-Thiel, et al.
Biochemical and Biophysical Research Communications|April 28, 2004
Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosteroneKarin Rossol-Haseroth, Qian Zhou, Sabine Braun, et al.
Thrombosis and Haemostasis|September 28, 2012
Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgeryJob Harenberg, Svetlana Marx, Ola E Dahl, et al.
Kidney International|September 13, 2003
Early aldosterone up-regulated genes: new pathways for renal disease?Markus Kellner, Angela Peiter, Mathias Hafner, et al.
Pageof 17